Science Library · Peptide bioregulator

Cardiogen the science.

Cardiogen is a short peptide bioregulator reported with the sequence Ala-Glu-Asp-Arg, studied within a body of (largely Russian) research literature on tissue-specific peptide bioregulators. Investigators have examined short peptides of this kind for their reported effects on gene expression and cell activity in cardiac-tissue models. Everything below comes from laboratory and animal research.

View the Cardiogen product page

Ala-Glu-Asp-Arg
Reported sequence
Short peptide
Modality
Preclinical
Evidence stage
Animal & cell
Model systems
Cardiogen research vial

How it works

Mechanism at a glance

Compound
Cardiogen
Action
Studied as a tissue-specific bioregulator
Effect
Gene-expression & cell-activity models
Studied for
Cardiac-tissue research

Evidence to date

Evidence to date: cell and animal models, largely from peptide-bioregulator research literature. No rigorous human-trial data.

What it is

Cardiogen belongs to a family of very short peptides — typically two to four amino acids — that researchers refer to as peptide bioregulators. The concept, developed primarily in Russian gerontology and peptide-chemistry research, proposes that specific short peptide sequences are associated with specific tissue types and may interact with gene-expression programs in those tissues.

Cardiogen is the tissue label applied to the cardiac-associated sequence in this research framework. It is studied as a laboratory tool peptide; the broader bioregulator literature remains debated and is not widely replicated outside its originating research groups.

Pathways under study

Peptide-bioregulator research with short peptides of this class is generally organized around a few ideas:

  • Gene-expression modulation — the central hypothesis is that short peptides can interact with DNA or transcriptional programs in a tissue-associated way.
  • Cell-activity models — effects on cultured cells, proliferation, and differentiation are common experimental readouts.
  • Tissue-maintenance framing — the literature situates these peptides in the context of aging and tissue function, mostly in animal models.

What research has explored

Published research on Cardiogen and related short peptide bioregulators is preclinical and concentrated in a specific research tradition:

  • Bioregulator literature. A body of peptide-chemistry and gerontology work describes short peptides being studied for tissue-associated activity, including cardiac-tissue models.
  • Replication caveats. Much of this literature comes from a limited set of research groups and is not extensively replicated in independent international journals; readers should weigh it accordingly.

These are observations in cells and animals within a specific research framework. They do not establish human safety, efficacy, or benefit.

Current state of the evidence

The Cardiogen evidence base is preclinical and drawn largely from the peptide-bioregulator research literature, with limited independent replication. No human safety, dosing, or efficacy is established here. Cardiogen is supplied strictly as a research material for laboratory investigation.

Compound Snapshot

At a glance

Identity

What is Cardiogen?

Type
Short peptide bioregulator
Reported sequence
Ala-Glu-Asp-Arg (AEDR)
Modality
Synthetic short peptide
Research framing
Tissue-associated gene-expression models
Research family
Cellular health / cardiac
Use classification
Research Use Only
PubChem Database

Evidence base

Research maturity

Preclinical Animal & in vitro Limited replication
Maturity Preclinical Cell and animal models within the peptide-bioregulator research literature; limited independent replication.
Translation Not established in humans Findings within this research framework do not establish human safety, dosing, or benefit.

Sources & References

Peer-reviewed research and database records

PubChem

Cardiogen / short peptide bioregulator compound search

NIH PubChem lookup for molecular identity and structure records. View Source

PubMed

Peptide bioregulator literature search

NCBI PubMed index for short peptide bioregulator primary papers and reviews. View Source

PubMed

Cardiogen peptide literature search

NCBI PubMed index for Cardiogen-related records. View Source

For research use only. Not for human or veterinary use. These products have not been evaluated by the FDA. Nothing on this page is medical advice or a therapeutic claim.

Catalog

Explore Cardiogen.

View product